MY203314A - Vaporisable formulation - Google Patents

Vaporisable formulation

Info

Publication number
MY203314A
MY203314A MYPI2020005325A MYPI2020005325A MY203314A MY 203314 A MY203314 A MY 203314A MY PI2020005325 A MYPI2020005325 A MY PI2020005325A MY PI2020005325 A MYPI2020005325 A MY PI2020005325A MY 203314 A MY203314 A MY 203314A
Authority
MY
Malaysia
Prior art keywords
vaporisable formulation
cooling agent
vaporisable
formulation
menthol
Prior art date
Application number
MYPI2020005325A
Other languages
English (en)
Inventor
Klaus Mathie
Sanchez Pena Maria Montserrat
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of MY203314A publication Critical patent/MY203314A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MYPI2020005325A 2018-05-03 2019-05-03 Vaporisable formulation MY203314A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1807305.6A GB201807305D0 (en) 2018-05-03 2018-05-03 Vaporisable formulation
PCT/GB2019/051244 WO2019211629A1 (en) 2018-05-03 2019-05-03 Vaporisable formulation

Publications (1)

Publication Number Publication Date
MY203314A true MY203314A (en) 2024-06-24

Family

ID=62598261

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2020005325A MY203314A (en) 2018-05-03 2019-05-03 Vaporisable formulation

Country Status (13)

Country Link
US (1) US20210368850A1 (enExample)
EP (1) EP3787429A1 (enExample)
JP (2) JP7258911B2 (enExample)
KR (2) KR20230151065A (enExample)
CN (1) CN112074201A (enExample)
AU (2) AU2019264022A1 (enExample)
BR (1) BR112020021341A2 (enExample)
CA (2) CA3190409A1 (enExample)
GB (1) GB201807305D0 (enExample)
IL (2) IL277973B2 (enExample)
MX (1) MX2020011664A (enExample)
MY (1) MY203314A (enExample)
WO (1) WO2019211629A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12588700B2 (en) 2019-12-02 2026-03-31 Jt International Sa E-liquid composition comprising 1,3-propanediol below 50% by weight of the composition
GB202006633D0 (en) * 2020-05-05 2020-06-17 Nicoventures Holdings Ltd Aerosol generating material
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
GB202110541D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system
CA3242529A1 (en) * 2022-01-14 2023-07-20 Nicoventures Trading Limited Aerosolisable material

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5097886A (enExample) * 1973-12-28 1975-08-04
JP2005512554A (ja) * 2001-12-19 2005-05-12 ベクター・タバコ・インコーポレーテッド タバコ製品に清涼効果を付与する方法および組成物
US6897195B2 (en) * 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent
CA2592635C (en) * 2004-12-29 2013-02-12 Wm. Wrigley Jr. Company Combinations of cooling agents for use in confections
WO2007041035A2 (en) 2005-09-30 2007-04-12 Wm. Wrigley Jr. Company Oral composition and method for stress reduction associated with smoking cessation
WO2007089652A2 (en) * 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
US20100056636A1 (en) 2006-12-20 2010-03-04 Stefan Michael Furrer N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof
JP2009148233A (ja) 2007-12-21 2009-07-09 Japan Tobacco Inc 喫煙物品
WO2009140783A1 (en) * 2008-05-22 2009-11-26 Givaudan Sa Cooling composition
DE102010002558A1 (de) * 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
ES2377785B2 (es) 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
US9854839B2 (en) * 2012-01-31 2018-01-02 Altria Client Services Llc Electronic vaping device and method
KR102705152B1 (ko) * 2013-05-06 2024-09-09 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
US20160128944A1 (en) * 2013-06-04 2016-05-12 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
US9877511B2 (en) * 2013-07-24 2018-01-30 Altria Client Services Llc Electronic smoking article
US20150313275A1 (en) * 2014-04-30 2015-11-05 Altria Client Services, Inc. Liquid aerosol formulation of an electronic smoking article
JP6061900B2 (ja) 2014-07-24 2017-01-18 長谷川香料株式会社 Ｗｓ−１２の微粒子およびこれを含有する冷感剤組成物
TWI693031B (zh) 2015-04-30 2020-05-11 瑞士商菲利浦莫里斯製品股份有限公司 包含具高通氣度之可卸式清新劑遞送元件的氣溶膠產生物件
GB2544468A (en) * 2015-11-12 2017-05-24 Jaytee Biosciences Ltd Liquid formulation
US20170172204A1 (en) * 2015-12-18 2017-06-22 Altria Client Services Llc Strength enhancers and method of achieving strength enhancement in an electronic vapor device
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof
JP6770864B2 (ja) 2016-09-30 2020-10-21 アース製薬株式会社 スプレー型芳香剤
CN106962971A (zh) 2017-04-11 2017-07-21 深圳瀚星翔科技有限公司 电子烟烟油及其制备方法

Also Published As

Publication number Publication date
JP7258911B2 (ja) 2023-04-17
RU2020136071A (ru) 2022-05-04
EP3787429A1 (en) 2021-03-10
IL305868B2 (en) 2025-03-01
JP7682942B2 (ja) 2025-05-26
NZ768771A (en) 2024-07-05
AU2022218470B2 (en) 2024-07-04
RU2020136071A3 (enExample) 2022-05-04
KR20230151065A (ko) 2023-10-31
KR102594623B1 (ko) 2023-10-25
CN112074201A (zh) 2020-12-11
JP2021523690A (ja) 2021-09-09
BR112020021341A2 (pt) 2021-01-19
US20210368850A1 (en) 2021-12-02
IL305868A (en) 2023-11-01
KR20200136033A (ko) 2020-12-04
AU2019264022A1 (en) 2020-10-29
IL277973B1 (en) 2023-10-01
IL277973A (en) 2020-11-30
CA3190409A1 (en) 2019-11-07
MX2020011664A (es) 2020-12-10
IL305868B1 (en) 2024-11-01
GB201807305D0 (en) 2018-06-20
CA3099021A1 (en) 2019-11-07
JP2023085453A (ja) 2023-06-20
WO2019211629A1 (en) 2019-11-07
IL277973B2 (en) 2024-02-01
AU2022218470A1 (en) 2022-09-08

Similar Documents

Publication Publication Date Title
MX2020011664A (es) Formulacion vaporizable.
SA521422143B1 (ar) 15-pgdh مثبط
GEAP202215671A (en) Microbiocidal thiazole derivatives
GEAP202215378A (en) Microbiocidal thiazole derivatives
GEP20227428B (en) Heterocyclic compounds as immunomodulators
PH12018501099A1 (en) Novel biphenyl compound or salt thereof
MX2024013464A (es) Antagonistas del receptor de tipo toll 7/8 (tlr7/8) y usos de los mismos
CR20200116A (es) Compuestos de bisamida que activan el sarcómero y sus usos
TW201613568A (en) Pharmaceutical composition comprising novel hydroxamic acid derivative or salt thereof
MX2022011896A (es) Composiciones oftalmicas.
NZ608846A (en) Aryloxyurea compound and pest control agent
MX2019004294A (es) Derivados de fenilamina 4-sustituidos y su uso para proteger cultivos al combatir microorganismos fitopatogenicos indeseados.
MX388612B (es) Intermediarios para preparar herbicidas de piridazinona y proceso para prepararlos.
JOP20200155A1 (ar) صور متعددة الأشكال
EP4706394A3 (en) Use of alkoxypyrazoles as nitrification inhibitors
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
MX385203B (es) Compuestos y métodos para tratar infecciones bacterianas.
AU2017263385A1 (en) Glyphosate formulations containing amidoalkylamine surfactants
EP4606435A3 (en) Pharmaceutical composition comprising poorly soluble basic agent
MX2018004055A (es) Compuestos de imino con un sustituyente de 2-cloropirimidin-5-ilo como agentes de control de plagas.
PH12021551103A1 (en) 1,3,4-oxadiazolone compound and medicine
PH12019502170A1 (en) Combination of isoindolinone derivatives with sgi-110
MX2017007385A (es) Estabilizacion de nanoparticulas hexagonales de nitruro de boro.
MX381234B (es) Agente preventivo y/o terapéutico de enfermedad inmune.
MY177032A (en) Aqueous composition